Clifford G. Robinson

Author

Washington University in St. Louis ORCID

Also Known As

Angel Qin, C G Robinson, C Robinson, C. ROBINSON, C. Robinson, C.G. Robinson, CHARLES ROBINSON, Cliff G Robinson, Cliff G. Robinson, Cliff Grant Robinson

584

Publications

15.7K

Citations

H-Index

120

Concepts

All Affiliations

Washington University in St. Louis NRG Oncology The University of Texas MD Anderson Cancer Center The University of Texas Southwestern Medical Center Emory University

About

Clifford G. Robinson is an author at Washington University in St. Louis specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	92	8.2K
2	Health Sciences	33	56	4.3K
3	Engineering	4	4	71
4	Social Sciences	4	4	137
5	Public Health	3	3	117

Clifford G. Robinson

160

Publications

13.9K

Citations

H-Index

Page 1

	Year	Citations
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, The Lancet Oncology Consolidation CarboplatinOncologyRadiation TherapyRtog 0617Stage Iiia	2015	2K
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 Paul D. Brown, Vinai Gondi, Stephanie L. Pugh, Journal of Clinical Oncology	2020	783
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial Stephen G. Chun, Chen Hu, Hak Choy, Journal of Clinical Oncology Randomized Clinical TrialSurgical OncologyImrt OutcomesSecondary AnalysisTreatment Verification	2016	715
Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia Phillip S. Cuculich, Matthew R. Schill, Rojano Kashani, New England Journal of Medicine	2017	617
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Journal of Clinical Oncology	2019	540
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen Lauren E. Henke, Rojano Kashani, Clifford G. Robinson, Radiotherapy and Oncology	2017	412
Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia Clifford G. Robinson, Pamela Samson, Kaitlin Moore, Circulation	2019	398
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer Robert Timmerman, Rebecca Paulus, Harvey I. Pass, JAMA Oncology Radiation MedicineSurgical OncologyCancer TherapeuticsRadiation TherapyTreatment Verification	2018	361
Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications Sahaja Acharya, Benjamin W. Fischer‐Valuck, Rojano Kashani, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNeuro-oncologyRadiation MedicineMedical ImagingRadiation Therapy	2015	291
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer Gregory M.M. Videtic, Rebecca Paulus, Anurag K. Singh, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyStudy Comparing 2MedicineClinical Radiation Oncology	2018	283

Page 1